Mohammadi-Samani Soliman, Taghipour Behzad
Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences , Shiraz , Iran.
Pharm Dev Technol. 2015 Jun;20(4):385-93. doi: 10.3109/10837450.2014.882940. Epub 2014 Feb 3.
During the last decades, many of the poorly controlled diseases were treated using newly developed peptide and proteins. Although the majority of such therapeutic moieties have undesirable pharmacokinetic properties and there is still need for administration in relatively short intervals, new formulation strategies allow us to select appropriate carriers in the development of these compounds. Polyesters such as polylactide-co-glycolide were used to stabilize and control the release rate of peptide and proteins. Besides many appropriate characteristics, these polymers, however, have some limitations and drawbacks which limit their extensive use in formulation. In this review, the factors affecting the loading, release behavior, particle size distribution and burst effect were evaluated and appropriate suggestions to optimize the formulation with these polymers were proposed.
在过去几十年中,许多控制不佳的疾病都使用新开发的肽和蛋白质进行治疗。尽管大多数此类治疗部分具有不良的药代动力学特性,并且仍然需要相对较短的间隔给药,但新的制剂策略使我们能够在这些化合物的开发中选择合适的载体。聚乳酸-乙醇酸共聚物等聚酯被用于稳定和控制肽和蛋白质的释放速率。然而,除了许多合适的特性外,这些聚合物也有一些局限性和缺点,限制了它们在制剂中的广泛应用。在本综述中,评估了影响负载、释放行为、粒径分布和突释效应的因素,并提出了用这些聚合物优化制剂的适当建议。